FENC
Fennec Pharmaceuticals Inc

1,303
Mkt Cap
$218.76M
Volume
911,773.00
52W High
$9.92
52W Low
$3.96
PE Ratio
-33.03
FENC Fundamentals
Price
$7.86
Prev Close
$7.69
Open
$8.75
50D MA
$8.69
Beta
0.89
Avg. Volume
73,483.74
EPS (Annual)
-$0.016
P/B
-49.10
Rev/Employee
$1.49M
Loading...
Loading...
News
all
press releases
Adherex Technologies (NASDAQ:FENC) Rating Increased to Strong-Buy at Wall Street Zen
Wall Street Zen upgraded Adherex Technologies from a "buy" rating to a "strong-buy" rating in a research note on Saturday...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Adherex Technologies (NASDAQ:FENC) Announces Quarterly Earnings Results
Adherex Technologies (NASDAQ:FENC - Get Free Report) issued its earnings results on Thursday. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.16...
MarketBeat·2d ago
News Placeholder
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates
Adherex Technologies (FENC) delivered earnings and revenue surprises of +75.00% and +11.62%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of +26.63% and +294.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below 50-Day Moving Average - What's Next?
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Below 50 Day Moving Average - What's Next...
MarketBeat·8d ago
News Placeholder
Rosty Raykov Sells 10,000 Shares of Adherex Technologies (NASDAQ:FENC) Stock
Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) Director Rosty Raykov sold 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 5th. The shares were sold...
MarketBeat·9d ago
News Placeholder
Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates
Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +150.00% and +8.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Adherex Technologies (FENC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·17d ago
News Placeholder
Are Options Traders Betting on a Big Move in Fennec Pharmaceuticals Stock?
Investors need to pay close attention to FENC stock based on the movements in the options market lately.
Zacks·25d ago
News Placeholder
New Strong Sell Stocks for Oct. 15th
FENC, BABA and ALCO have been added to the Zacks Rank #5 (Strong Sell) List on October 15, 2025.
Zacks·1mo ago

Latest FENC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.